Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2007

View Archived Issues

Recent Merck & Co. and Merck Sharp & Dohme patent discloses new antipsychotic agents

Novel therapeutic agents for respiratory disorders described in recent patents

Recent patents disclose novel compounds targeting HCV infection

Liposome encapsulated OGG1 may be useful to promote DNA repair in UV-irradiated skin cells

Roche reports phase I data on R-667 for the treatment of emphysema

VASTox to advance programs targeting symptoms of Parkinson's disease

TAK-390MR demonstrates extended exposure in humans

Clinical trials of new drugs for Crohn's disease and ulcerative colitis

Tolerability and activity of MK-0822 on bone resorption markers in healthy postmenopausal women

Natural blood components inhibit HIV-1 entry by targeting the gp41 fusion peptide

Enrollment completed in phase III trial of CellCept in pemphigus vulgaris

Arete Therapeutics raises additional financing

New trial studies everolimus-eluting self-expanding stent for PAD

Chidamide begins phase I study in China

Suspension of phase III study of Cloretazine in relapsed AML

CoGenesys reports milestones from licensing agreements

AEOL-10150 to be studied in mustard gas-mediated lung injury

AAGP increases recovery rate of cryopreserved stem cells

German sites cleared to begin phase II study of MORAb-003 in ovarian cancer

BioDiem reveals new vaccine strategy for potential influenza pandemic

Genvax immunostimulant elicits cellular immune response in prostate cancer

CE Mark for Taxus Liberte Long stent

Nalmefene licensing agreement enters into force

Multikine increases long-term overall survival in head and neck cancer

Results from phase III trauma trial with PolyHeme

CHF-5407 profiled as a novel M3 antagonist for the treatment of COPD

Snapshots of preclinical antiviral studies

Japanese approval for Glufast in combination with alpha-GI

BioMarin files NDA for Kuvan for PKU

Mircera recommended for approval in E.U.

Lacosamide filed in Europe as adjunctive therapy of epilepsy

Siena Biotech and Roche collaborate in neurodegenerative diseases

Salvacyl/Moapar completes European mutual recognition procedure

Levitra 20 mg tablet approved in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...